The at-home molecular testing market size is projected to be worth USD 10.2 billion in 2023. The market is likely to surpass USD 18.1 billion by 2033 at a CAGR of 5.9% during the forecast period. Increased infectious illnesses and an increase in the number of diabetes patients around the world are driving the market expansion.
For instance, monkey pox and other infectious illnesses pose a severe threat to public health and economic development in all nations. Additionally, the need for early detection of various diseases and growing awareness of them are fueling market expansion.
The prospective growth of the at-home testing market was influenced by the population's growing awareness of home care testing.
Other Drivers Propelling the Demand for At-home Molecular Testing Market include:
Challenges for Companies /Manufacturers in the At-home Molecular Testing Market:
Opportunities in the At-home Molecular Testing Market Industry:
Latest Trends in the At-home Molecular Testing Market:
| Attributes | Details |
|---|---|
| At-home Molecular Testing Market Size (2023) | USD 10.2 billion |
| At-home Molecular Testing Market Projected Size (2033) | USD 18.1 billion |
| Value CAGR (2023 to 2033) | 5.9% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2017 to 2022, the global at-home molecular testing market experienced a CAGR of 5.4%, reaching a market size of USD 10.2 billion in 2023.
From 2017 to 2022, the global at-home molecular testing market industry witnessed steady growth due to the increased awareness and acceptance of at-home molecular testing. The at-home molecular testing market was in its infancy, primarily focused on genetic testing for ancestry and genealogy purposes.
ompanies like 23andMe and AncestryDNA gained popularity, attracting consumers interested in exploring their genetic heritage. The market witnessed increased awareness and acceptance of at-home molecular testing during this period. More consumers recognized the potential benefits of understanding their genetic health risks and gaining personalized insights. The market diversified to include tests for traits, wellness, and lifestyle factors, such as diet and exercise recommendations based on genetic profiles.
Future Forecast for At-home Molecular Testing Market Industry:
Looking ahead, the global at-home molecular testing market industry is expected to rise at a CAGR of 5.9% from 2023 to 2033. During the forecast period, the market size is expected to reach USD 18.1 billion by 2033.
The at-home molecular testing market industry is expected to continue its growth trajectory from 2023 to 2033. The at-home molecular testing market is expected to witness an expansion of the test menu, offering a wider range of genetic and molecular tests.
As scientific knowledge expands, more disease markers, genetic variants, and actionable insights will be identified, leading to the development of new tests. This diversification will attract a larger consumer base and drive market growth.
The growing focus on personalized medicine and preventive healthcare will fuel the demand for at-home molecular testing. Individuals are increasingly interested in understanding their genetic predispositions, optimizing their health choices, and monitoring disease risks. At-home testing provides a convenient and accessible means to achieve these goals.
| Country | The United States |
|---|---|
| Market Size (USD billion) by End of Forecast Period (2033) | USD 5.6 billion |
| CAGR % 2023 to End of Forecast (2033) | 7.2% |
The at-home molecular testing market industry in the United States is expected to reach a market size of USD 5.6 billion by 2033, expanding at a CAGR of 7.2%. Due to the rising demand for at home diabetic testing kits. In the United States, more than 130 million persons have diabetes or prediabetes, according to the Centers for Disease Control and Prevention 2022. Such growing prevalence of diabetes in the country, the demand for at home molecular testing market is high.
| Country | The United Kingdom |
|---|---|
| Market Size (USD billion) by End of Forecast Period (2033) | USD 689.1 million |
| CAGR % 2023 to End of Forecast (2033) | 6.8% |
The at-home molecular testing market industry in the United Kingdom is expected to reach a market share of USD 689.1 million, expanding at a CAGR of 6.8% during the forecast period. The United Kingdom market is projected to growth of the market due to the growing personalized medicine initiatives. The United Kingdom has been at the forefront of personalized medicine initiatives, aiming to provide tailored healthcare based on an individual's genetic profile. At-home molecular testing plays a crucial role in these initiatives, allowing individuals to access genetic information, identify disease risks, and participate in research studies to advance personalized healthcare.
| Country | China |
|---|---|
| Market Size (USD billion) by End of Forecast Period (2033) | USD 1.30 billion |
| CAGR % 2023 to End of Forecast (2033) | 5.1% |
The at-home molecular testing market industry in China is anticipated to reach a market size of USD 1.30 billion, moving at a CAGR of 5.1% during the forecast period. The at-home molecular testing market industry in China is expected to grow prominently due to the increasing chronic disease. China is facing a rising burden of chronic diseases, such as cardiovascular diseases, diabetes, and cancer.
At-home molecular testing offers a way for individuals to monitor their health, detect diseases early, and take preventive measures. The ability to access testing from the comfort of their homes aligns with the increasing emphasis on preventive healthcare.
| Country | Japan |
|---|---|
| Market Size (USD billion) by End of Forecast Period (2033) | USD 1.12 billion |
| CAGR % 2023 to End of Forecast (2033) | 5.8% |
The at-home molecular testing market industry in Japan is estimated to reach a market size of USD 1.12 billion by 2033, thriving at a CAGR of 5.8%. The market in Japan is predicted to grow because of the growing technological advancements.
Japan has a well-established e-commerce infrastructure and a high penetration of smartphones. This has facilitated the growth of online platforms and marketplaces for at-home molecular testing kits. The ease of purchasing and accessing these kits online has contributed to the rising demand in the country.
| Country | South Korea |
|---|---|
| Market Size (USD billion) by End of Forecast Period (2033) | USD 253.9 million |
| CAGR % 2023 to End of Forecast (2033) | 3.6% |
The at-home molecular testing market industry in South Korea is expected to reach a market size of USD 253.9 million, expanding at a CAGR of 3.6% during the forecast period. The market in South Korea is forecasted to witness growth due to the increased awareness and acceptance. There has been a growing awareness and acceptance of at-home molecular testing among the general population in the South Korea. Consumers are increasingly interested in understanding their genetic heritage, health risks, and ancestry. This has contributed to the rising demand for at-home genetic testing kits.
Principal Consultant
The cassettes are expected to dominate the at-home molecular testing market industry with a CAGR of 6.7% from 2023 to 2033. This segment captures a significant market share in 2023 due to its rapid testing procedures, high efficiency, and improved testing kits.
According to the needs of the consumer, diagnostic cassettes for rapid test for diagnostic kits can be used in a single way or many ways (two or four ways). For immediate results, Plastic Cassettes for Rapid Test (Cassettes for Diagnostic Kits) are frequently utilized. For the best outcomes, it also guarantees improved buffer flow with the right pressure points through the strip.
Infectious diseases are expected to dominate the at-home molecular testing market industry with a CAGR of 6.7% from 2023 to 2033. This segment captures a significant market share in 2023 as incidences of infectious diseases in the globe is on the rise.
The prevalence of infectious diseases in developed and developing regions will have a beneficial impact on market growth. The increasing number of prescriptions for at-home infectious illness diagnostic tests is due to the diagnosis and management of such infections.
The blood sample segment is expected to dominate the at-home molecular testing market industry with a CAGR of 5.5% from 2023 to 2033 and is expected to hold market share of 42.4% in 2023. Blood testing are extremely common. They aid clinicians in the detection of certain diseases and ailments.
They also aid in the evaluation of organ function and the effectiveness of treatments. One of the most popular blood tests is the complete blood count (CBC). It is frequently performed as part of a standard checkup. This test evaluates a variety of blood components, including red blood cells, white blood cells, and platelets.
The drug store in dominating the at home molecular testing market with the CAGR of 6.2%. The ease of availability of the testing kits without prescription in the drug store the adoption is high.
The at-home molecular testing sector is fiercely competitive, with many companies fighting for market dominance. To stay ahead of the competition in such a circumstance, essential players must employ smart techniques.
Key Strategies Used by the Participants
To produce innovative goods that increase efficacy, dependability, and cost-effectiveness, businesses make significant investments in research and development. Product innovation enables companies to stand out from the competition while also meeting the shifting needs of their customers.
Strategic alliances and partnerships with other businesses are regularly formed by major players in an industry to take advantage of each other's advantages and expand their market reach. Through such arrangements, businesses may also obtain access to new technologies and markets.
The market for at-home molecular testing is rising quickly in developing nations like China and India. To boost their presence in these regions, major companies are expanding their distribution networks and building regional manufacturing sites.
Key companies in the at-home molecular testing market routinely employ mergers and acquisitions to strengthen their market positions, broaden their product offerings, and enter new markets.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key Developments in the At-home Molecular Testing Market:
The at-home molecular testing market CAGR for 2033 is 5.9%.
The North America region is the leading region in the market.
The projected market value of the market for 2033 is US$ 10.2 billion.
Key players are developing the market by developing innovative tests.
China, India, the United States, Japan, and Germany are the major countries in this market.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Value Added Insights 5. Market Background 6. Global Market Volume (in Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033 7. Global Market - Pricing Analysis 8. Global Market Demand (in Value or Size in USD Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product 9.1. Cassettes 9.2. Strips 9.3. Test Panels 9.4. Dip Cards 9.5. Midstreams 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Test Type 10.1. Pregnancy Tests 10.2. HIV Tests 10.3. Diabetes 10.4. Infectious Diseases 10.5. Glucose Tests 10.6. Ovulation Predictor Tests 10.7. Drug Abuse Tests 10.8. Others 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Sample Type 11.1. Urine 11.2. Blood 11.3. Saliva 11.4. Others 12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Distribution Channel 12.1. Retail Pharmacies 12.2. Drug Stores 12.3. Supermarkets/Hypermarkets 12.4. Online Pharmacies 13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region 13.1. North America 13.2. Latin America 13.3. Europe 13.4. South Asia 13.5. East Asia 13.6. Oceania 13.7. Middle East and Africa (MEA) 14. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 19. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 20. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 21. Market Structure Analysis 22. Competition Analysis 22.1. Abbott 22.2. Rapikit 22.3. Becton and Dickinson 22.4. Cardinal Health 22.5. B. Braun Melsungen AG 22.6. Piramal Enterprises Ltd. 22.7. Siemens Healthcare GmbH 22.8. Quidel Corporation 22.9. Bionime Corporation 22.10. SA Scientific 22.11. ARKRAY USA, Inc. 22.12. Nova Biomedical 22.13. AdvaCare Pharma 22.14. AccuBioTech Co., Ltd. 22.15. Atlas Medical UK 22.16. TaiDoc Technology Corporation 22.17. Drägerwerk AG & Co. KGaA 22.18. F. Hoffmann-La Roche Ltd 22.19. Sensing Self 22.20. PTE. Ltd 22.21. Atomo Diagnostics 22.22. Mankind Pharma 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports
At-home Molecular Testing Market
